WallStreetZenWallStreetZen

NYSE: STE
Steris PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

STE past earnings growth

How has STE's earnings growth performed historically?
Company
234.71%
Industry
45.15%
Market
55.21%
STE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
STE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
STE's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

STE past revenue growth

How has STE's revenue growth performed historically?
Company
12.5%
Industry
10.49%
Market
17.39%
STE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
STE's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

STE earnings and revenue history

Current Revenue
$5.1B
Current Earnings
$400.1M
Current Profit Margin
7.8%

STE Return on Equity

Current Company
6.3%
Current Industry
9.3%
Current Market
33.8%
STE's Return on Equity (6.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when STE announces earnings.

STE Return on Assets

Current Company
3.6%
Current Industry
5.5%
STE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

STE Return on Capital Employed

Current Company
7.47%
Current Industry
8.9%
STE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

STE vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
STE$5.13B$1.23B$400.09M+12.57%+1.44%
ZBH$7.52B$2.19B$997.10M-0.90%+121.57%
DXCM$3.93B$1.02B$666.90M+26.36%+32.37%
PHG$19.54B$1.18B-$501.08M-0.62%N/A
ALGN$3.94B$813.73M$447.03M+12.49%+2.48%
View Top Medical Device Stocks

STE earnings dates

Next earnings date
Nov 5, 2024

Steris Earnings & Revenue FAQ

What were STE's earnings last quarter?

On Invalid Date, Steris (NYSE: STE) reported Q2 2024 earnings per share (EPS) of $1.47, up 17.6% year over year. Total Steris earnings for the quarter were $145.40 million. In the same quarter last year, Steris's earnings per share (EPS) was $1.25.

If you're new to stock investing, here's how to buy Steris stock.

What was STE's earnings growth in the past year?

As of Q3 2024, Steris's earnings has grown 234.71% year over year. This is 189.56 percentage points higher than the US Medical Devices industry earnings growth rate of 45.15%. Steris's earnings in the past year totalled $400.09 million.

What is STE's earnings date?

Steris's earnings date is Invalid Date. Add STE to your watchlist to be reminded of STE's next earnings announcement.

What was STE's revenue last quarter?

On Invalid Date, Steris (NYSE: STE) reported Q2 2024 revenue of $1.28 billion up 8.12% year over year. In the same quarter last year, Steris's revenue was $1.18 billion.

What was STE's revenue growth in the past year?

As of Q3 2024, Steris's revenue has grown 12.5% year over year. This is 2.01 percentage points higher than the US Medical Devices industry revenue growth rate of 10.49%. Steris's revenue in the past year totalled $5.13 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.